Akebia Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AKBA Nasdaq 2834 https://akebia.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akebia Therapeutics Inc

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Dec 3rd, 2019 9:06 pm
Options Traders Expect Huge Moves in Akebia Therapeutics (AKBA) Stock - Dec 2nd, 2019 1:57 pm
Introducing Akebia Therapeutics (NASDAQ:AKBA), The Stock That Slid 52% In The Last Five Years - Dec 2nd, 2019 10:09 am
5 “Strong Buy” Biotech Stocks With More Than 80% Upside - Nov 27th, 2019 2:45 pm
Large Option Trader Betting On Biotech Stock Akebia Following Insider Buys - Nov 26th, 2019 5:26 pm
Akebia Therapeutics to Present at Upcoming Investor Conferences - Nov 21st, 2019 1:00 pm
Edited Transcript of AKBA earnings conference call or presentation 12-Nov-19 2:00pm GMT - Nov 20th, 2019 10:28 pm
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Nov 12th, 2019 2:15 pm
Akebia Secures $100 Million Non-Dilutive Term Loan Financing; Reports Third Quarter 2019 Financial Results - Nov 12th, 2019 12:57 pm
The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat - Nov 12th, 2019 12:20 pm
Akebia Announces Positive 52-week Efficacy and Safety Data for Vadadustat from Two Pivotal Phase 3 Studies in Japanese Patients with Anemia Due to Chronic Kidney Disease - Nov 9th, 2019 5:15 pm
Will Akebia Therapeutics (AKBA) Report Negative Earnings Next Week? What You Should Know - Nov 5th, 2019 3:33 pm
Can Akebia Therapeutics (NASDAQ:AKBA) Afford To Invest In Growth? - Nov 1st, 2019 1:18 pm
Akebia Therapeutics Inc (AKBA) Is Burning These Hedge Funds - Oct 30th, 2019 1:30 pm
Akebia Therapeutics to Report Third Quarter 2019 Financial Results and Discuss Recent Business Highlights - Oct 28th, 2019 12:00 pm
Akebia Announces Nine Abstracts Accepted for Presentation at the American Society of Nephrology Kidney Week 2019 Annual Meeting - Oct 24th, 2019 12:00 pm
The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch - Oct 16th, 2019 11:06 am
Akebia Files Lawsuit Against CMS for 2018 Action Rescinding Medicare Part D Coverage of FDA-Approved Auryxia® for its Iron Deficiency Anemia Indication and Imposing a Prior Authorization Requirement for its Hyperphosphatemia Indication - Oct 15th, 2019 8:46 pm